Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma

The gut microbiota is a well‐known prognostic factor and a modulator of treatment sensitivity in patients with cancers treated with immune checkpoint inhibitors. However, data on hepatocellular carcinoma (HCC) are lacking. This study aimed to evaluate the prognostic role of the gut microbiota and ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Ponziani, Francesca Romana, De Luca, Angela, Picca, Anna, Marzetti, Emanuele, Petito, Valentina, Del Chierico, Federica, Reddel, Sofia, Paroni Sterbini, Francesco, Sanguinetti, Maurizio, Putignani, Lorenza, Gasbarrini, Antonio, Pompili, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134810/
https://www.ncbi.nlm.nih.gov/pubmed/35261212
http://dx.doi.org/10.1002/hep4.1905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134810/
https://www.ncbi.nlm.nih.gov/pubmed/35261212
http://dx.doi.org/10.1002/hep4.1905

Ejemplares similares